Stay up to date with the most recent press releases and read about Norlase in the news.
The funding will support the expansion of Norlase’s innovative ophthalmic laser technology, reinforcing Denmark’s position as a hub for world-class med-tech innovation.
Dr. Jacob Philipsen, who succeeds co-founder David Hardwick, will lead the next phase of Norlase’s growth journey.
Norlase wins the Biomedical Optics 2025 PRISM Award. This marks Norlase’s second PRISM award win, following the success of LION.
Norlase announced it has received both FDA 510(k) clearance and CE Mark approval for the LYNX Pattern Scanning LIO.
Norlase announced it has received Health Canada Licensing for the ECHO Green Pattern Laser photocoagulator.
Norlase has elected Maya Barley, PhD, to its board of directors. Dr. Barley, the current CEO of Medis Medical Imaging Systems, brings to her role a wealth of experience from across the medical technology sector, as Norlase furthers its mission of delivering ophthalmic innovation to customers globally.
Norlase closes biggest investment round thus far. New funding will accelerate the production ramp-up of the ECHO pattern laser and other cutting edge laser treatment solutions.
Norlase announced it has received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.
Norlase receives EU MDR certification well ahead of the May 2024 deadline for medical device companies to comply.
Norlase is pleased to announce the expansion of its global distribution network in several markets, including the Americas, Asia-Pacific, Europe and the Middle East.
Douglas Cheah, with 30+ years of experience in the medical device industry, will help Norlase commercialize in the Asia Pacific region.
Norlase continues to expand the global reach of its revolutionary LEAF & LION green laser systems with the introduction of the lasers and distributors in Latin America.
Norlase is deeply concerned by the war in Ukraine. We’ve decided to donate to Unia Ophthalmica and encourage everyone who has the means to support organizations helping Ukraine during this crisis.
Guillermo Molina, with 15+ years of experience in international healthcare device sales, will help Norlase commercialize in Latin America & Canada.
Norlase has closed $10.6 million in Series B funding through London-based venture capital firm West Hill Capital.
Norlase announces that the United States Patent and Trademark Office has granted patent number 11,094,321 for a first-of-its-kind “Voice Control System for Ophthalmic Laser Systems.”
Norlase announces new distributor partnerships to continue accelerated market growth and global expansion of the Norlase family of green laser systems.
Norlase wins in the Medical Device category for photonics innovation with LION Green Laser
First-of-its-kind, all-in-one laser and indirect ophthalmoscope allows for retina treatment anywhere, anytime
Norlase expands family of Norlase green lasers into Eastern Europe, Middle East, Oceania and Southeast Asia
Norlase announces strategic partnerships to fuel growth of Norlase green laser systems
Norlase announces FDA clearance and U.S. launch of new LION laser system
Norlase appoints Taoufiq (TJ) Jellal as Vice President of Global Distribution
Norlase announces CE Mark Approval for LEAF Green Laser
Norlase appoints Andrew Berkowitz as Vice President of Global Sales
Norlase Enters Ophthalmic Market with New Single Spot Laser: LEAF
May 1, 2025
Spotlight on Technology & Technique: LYNX LIO Offers Pattern Delivery and Portability | Ophthalmology Management
Features include an integrated headset and a wireless tablet interface with voice commands.
October 9, 2023
Eye on the Future: Dr. R.V. Paul Chan Highlights the NORLASE® LION™ – Revolutionizing Laser Treatment | RetinaLink
We all know that new products come and go; however, in the case of the LION™ Laser Indirect Ophthalmoscope (LIO), they have a winner. Norlase is revolutionizing the laser space in several ways.
August 4, 2023
Norlase technology ‘disruptive’ in retina surgery space | Healio
From the ASRS annual meeting, Nassim Abreu-Arbaje, MD, discusses his positive experience using Norlase laser technology for retina surgery.
July 1, 2023
Making Laser Technology More Accessible | Retinal Physician
New ECHO green pattern laser photocoagulator overcomes challenges of traditional models.
May 30, 2023
November 4, 2022
Surgeon shares positive experience with Norlase lasers | Healio
David Almeida, MD, MBA, PhD, discusses his experience using Norlase lasers, which provide vitreoretinal surgeons with durable and adaptable tools that have also received positive responses from patients.
October 26, 2022
Portable laser technology receives high marks | Ophthalmology Times
Harit Bhatt, MD, a Chicagoland-area retinal surgeon, shared his experience with the LEAF and LION portable lasers at AAO 2022.
August 30, 2022
Turning Over a New LEAF | The Ophthalmologist
Prof. Giovanni Staurenghi weighs in about Norlase’s next-generation laser photocoagulator that offers unprecedented portability and ease of use.
June 2, 2022
New Technology: LION by Norlase | Drs. Berrocal & Associates
Dr. Maria H. Berrocal discusses the benefits of the Norlase LION laser indirect ophthalmoscope and how it helps her do what she is most passionate about.
March 28, 2022
The Laser Savior | The Ophthalmologist
Frank T. Kerkhoff, vitreoretinal and refractive surgeon at Eindhoven, The Netherlands, explains how Norlase’s LION saved the day.
January 26, 2022
The Laser’s Edge | The Ophthalmologist
Timeline tracking the key developments that culminated in the production of Norlase LION and LEAF technologies.
September 30, 2021
The Norlase LEAF and LION Revolution – Transforming Practice Efficiency | RetinaLink
Dr. Maria H. Berrocal discusses why Norlase technologies are ideal and seamless solutions for both the clinic and operating room.
March 1, 2021
A New Standard of Care – No Strings Attached | Ophthalmology Management
Dr. S.K. Steven Houston III, MD and Dr. John Kitchens, MD agree that LION’s features result in a device that delivers unparalleled efficiency.
February 1, 2021
Bringing Laser Technology Into the 21st Century | Retina Today
Dr. S.K. Steven Houston III, MD and Dr. John Kitchens, MD discuss the clinical advantages of the LION Green Laser, which keeps them mobile—in the office and between locations.
January 22, 2021
Untethered Portability of Retina Laser System Allows for Expanded Treatment | Ocular Surgery News
Dr. John Kitchens, MD shares how the LION Green Laser with its untethered portabiilty and compact laser technology has made the traditional indirect laser ophthalmoscope feel obsolete.
January 1, 2021
New Product Applications: The Laser Indirect Ophthalmoscope Gets Reinvented | Retinal Physician
Dr. S.K. Steven Houston III, MD dubs Norlase LION Green Laser “the most technologically advanced LIO on the market” and shares why LION will be a game changer.
Stay up to date with the most recent press releases and read about Norlase in the news.
The funding will support the expansion of Norlase’s innovative ophthalmic laser technology, reinforcing Denmark’s position as a hub for world-class med-tech innovation.
Dr. Jacob Philipsen, who succeeds co-founder David Hardwick, will lead the next phase of Norlase’s growth journey.
Norlase wins the Biomedical Optics 2025 PRISM Award. This marks Norlase’s second PRISM award win, following the success of LION.
Norlase announced it has received both FDA 510(k) clearance and CE Mark approval for the LYNX Pattern Scanning LIO.
Norlase announced it has received Health Canada Licensing for the ECHO Green Pattern Laser photocoagulator.
Norlase has elected Maya Barley, PhD, to its board of directors. Dr. Barley, the current CEO of Medis Medical Imaging Systems, brings to her role a wealth of experience from across the medical technology sector, as Norlase furthers its mission of delivering ophthalmic innovation to customers globally.
Norlase closes biggest investment round thus far. New funding will accelerate the production ramp-up of the ECHO pattern laser and other cutting edge laser treatment solutions.
Norlase announced it has received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.
Norlase receives EU MDR certification well ahead of the May 2024 deadline for medical device companies to comply.
Norlase is pleased to announce the expansion of its global distribution network in several markets, including the Americas, Asia-Pacific, Europe and the Middle East.
MAY 1, 2025
Spotlight on Technology & Technique: LYNX LIO Offers Pattern Delivery and Portability | Ophthalmology Management
Features include an integrated headset and a wireless tablet interface with voice commands.
OCTOBER 9, 2023
Eye on the Future: Dr. R.V. Paul Chan Highlights the NORLASE® LION™ – Revolutionizing Laser Treatment | RetinaLink
We all know that new products come and go; however, in the case of the LION™ Laser Indirect Ophthalmoscope (LIO), they have a winner. Norlase is revolutionizing the laser space in several ways.
AUGUST 4, 2023
Norlase technology ‘disruptive’ in retina surgery space | Healio
From the ASRS annual meeting, Nassim Abreu-Arbaje, MD, discusses his positive experience using Norlase laser technology for retina surgery.
JULY 1, 2023
Making Laser Technology More Accessible | Retinal Physician
New ECHO green pattern laser photocoagulator overcomes challenges of traditional models.
MAY 30, 2023
NOVEMBER 4, 2022
Surgeon shares positive experience with Norlase lasers | Healio
David Almeida, MD, MBA, PhD, discusses his experience using Norlase lasers, which provide vitreoretinal surgeons with durable and adaptable tools that have also received positive responses from patients.
OCTOBER 26, 2022
Portable laser technology receives high marks | Ophthalmology Times
Harit Bhatt, MD, a Chicagoland-area retinal surgeon, shared his experience with the LEAF and LION portable lasers at AAO 2022.
AUGUST 30, 2022
Turning Over a New LEAF | The Ophthalmologist
Prof. Giovanni Staurenghi weighs in about Norlase’s next-generation laser photocoagulator that offers unprecedented portability and ease of use.
JUNE 2, 2022
The Laser Savior | Drs. Berrocal & Associates
Dr. Maria H. Berrocal discusses the benefits of the Norlase LION laser indirect ophthalmoscope and how it helps her do what she is most passionate about.
MARCH 28, 2022
The Laser Savior | The Ophthalmologist
Frank T. Kerkhoff, vitreoretinal and refractive surgeon at Eindhoven, The Netherlands, explains how Norlase’s LION saved the day.
JANUARY 26, 2022
The Laser’s Edge | The Ophthalmologist
Timeline tracking the key developments that culminated in the production of Norlase LION and LEAF technologies.
SEPTEMBER 30, 2021
The Norlase LEAF and LION Revolution – Transforming Practice Efficiency | RetinaLink
Dr. Maria H. Berrocal discusses why Norlase technologies are ideal and seamless solutions for both the clinic and operating room.
MARCH 1, 2021
A New Standard of Care – No Strings Attached | Ophthalmology Management
Dr. S.K. Steven Houston III, MD and Dr. John Kitchens, MD agree that LION’s features result in a device that delivers unparalleled efficiency.
FEBRUARY 1, 2021
Bringing Laser Technology Into the 21st Century | Retina Today
Dr. S.K. Steven Houston III, MD and Dr. John Kitchens, MD discuss the clinical advantages of the LION Green Laser, which keeps them mobile—in the office and between locations.
JANUARY 22, 2021
Untethered Portability of Retina Laser System Allows for Expanded Treatment | Ocular Surgery News
Dr. John Kitchens, MD shares how the LION Green Laser with its untethered portabiilty and compact laser technology has made the traditional indirect laser ophthalmoscope feel obsolete.
JANUARY 1, 2021
New Product Applications: The Laser Indirect Ophthalmoscope Gets Reinvented | Retinal Physician
Dr. S.K. Steven Houston III, MD dubs Norlase LION Green Laser “the most technologically advanced LIO on the market” and shares why LION will be a game changer.
